Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$415K
Filings
21
Firms Hired
1
Active Period
2002–2009
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Employee Free Choice Act of 2009
2009 · second_quarter · Firm: C. R. BARD, INC
H.R. 1409 and S. 560, "The Employee Free Choice Act", to oppose provision that would eliminate employees' private balloting in deciding whether to have union representation.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1409
To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit.
2009 · second_quarter · Firm: C. R. BARD, INC
H.R. 422 (to amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit).
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 422
H.R. 1409 and S. 560, "The Employee Free Choice Act", to oppose provision that would eliminate employees' private balloting in deciding whether to have union representation.
Client expense: $20,000 · Firm income: —
Matched citations: S. 560
Lobbied select members of the House and Senate on H.R. 1409 and S. 560, "The Employee Free Choice Act", to oppose provision that would eliminate employees' private balloting in deciding whether to have union representation.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1409
Lobbied select members of the House and Senate on H.R. 1409 and S. 560, "The Employee Free Choice Act", to oppose provision that would eliminate employees' private balloting in deciding whether to have union representation.
Client expense: $20,000 · Firm income: —
Matched citations: S. 560
American Samoa Possession Tax Credit Act of 2003
2008 · fourth_quarter · Firm: C. R. BARD, INC
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 1424
Renewable Energy and Job Creation Tax Act of 2008
2008 · fourth_quarter · Firm: C. R. BARD, INC
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 7060
Comparative Effectiveness Research Act of 2008
2008 · fourth_quarter · Firm: C. R. BARD, INC
Lobbying Senate Finance Committee staff and House staff on provisions in the Baucus-Conrad comparative effective bill, S. 3408, "The Comparative Effectiveness Research Act of 2008", and Section 904 of H.R. 3162, "Children's Health and Medicare Protection Act of 2007." Prepared materials for potential use in a public awareness campaign on prostate cancer in Congressional District of Rep. Jim Clyburn. Discussion of same with Clyburn staff. Lobbying strategy prepared for key provisions in "FDA Globalization Act" and Ensuring the Safety and Quality of Medical Products Act." Lobbying CMS Coverage Advisory Group regarding Medicare coverage of bariatric surgery device.
Client expense: $10,000 · Firm income: —
Matched citations: S. 3408
American Samoa Possession Tax Credit Act of 2003
2008 · fourth_quarter · Firm: C. R. BARD, INC
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 1424
Renewable Energy and Job Creation Tax Act of 2008
2008 · fourth_quarter · Firm: C. R. BARD, INC
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 7060
Comparative Effectiveness Research Act of 2008
2008 · fourth_quarter · Firm: C. R. BARD, INC
Lobbying Senate Finance Committee staff and House staff on provisions in the Baucus-Conrad comparative effective bill, S. 3408, "The Comparative Effectiveness Research Act of 2008", and Section 904 of H.R. 3162, "Children's Health and Medicare Protection Act of 2007." Prepared materials for potential use in a public awareness campaign on prostate cancer in Congressional District of Rep. Jim Clyburn. Discussion of same with Clyburn staff. Lobbying strategy prepared for key provisions in "FDA Globalization Act" and Ensuring the Safety and Quality of Medical Products Act." Lobbying CMS Coverage Advisory Group regarding Medicare coverage of bariatric surgery device.
Client expense: $10,000 · Firm income: —
Matched citations: S. 3408
American Samoa Possession Tax Credit Act of 2003
2008 · third_quarter · Firm: C. R. BARD, INC
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
Client expense: $5,000 · Firm income: —
Matched citations: H.R. 1424
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
2008 · third_quarter · Firm: C. R. BARD, INC
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of the Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Worked on lobbying strategy for House and Senate Import Safety discussion drafts.
Client expense: $5,000 · Firm income: —
Matched citations: H.R. 583
Medicare Improvements for Patients and Providers Act of 2008
2008 · third_quarter · Firm: C. R. BARD, INC
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of the Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Worked on lobbying strategy for House and Senate Import Safety discussion drafts.
Client expense: $5,000 · Firm income: —
Matched citations: H.R. 6331
Renewable Energy and Job Creation Tax Act of 2008
2008 · third_quarter · Firm: C. R. BARD, INC
Lobbying on tax extenders legislation: H.R. 1424 and the Dodd Amendment to H.R. 1424; H.R. 6049 and H.R. 7060 specifically to extend and strengthen the R&D tax credit provision.
Client expense: $5,000 · Firm income: —
Matched citations: H.R. 7060
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
2008 · third_quarter · Firm: C. R. BARD, INC
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of the Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Worked on lobbying strategy for House and Senate Import Safety discussion drafts.
Client expense: $5,000 · Firm income: —
Matched citations: S. 1042
Physician Payments Sunshine Act of 2007
2008 · third_quarter · Firm: C. R. BARD, INC
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
Client expense: $5,000 · Firm income: —
Matched citations: S. 2029
Transparency in Medical Device Pricing Act of 2007
2008 · third_quarter · Firm: C. R. BARD, INC
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
Client expense: $5,000 · Firm income: —
Matched citations: S. 2221
Medicare Improvements for Patients and Providers Act of 2008
2008 · third_quarter · Firm: C. R. BARD, INC
Lobbying member staff of House and Senate to extend current Medicare brachytherapy reimbursement payment methodology in H.R. 6331 and S. 3101, "Medicare Improvements for Patients and Providers Act of 2008"; modifications to CMS's OPPS rule. Lobbying member staff of the Senate on H.R. 583 and S. 1042 to exclude ultrasound guided vascular access procedures from the scope of the bill. Worked on lobbying strategy for House and Senate Import Safety discussion drafts.
Client expense: $5,000 · Firm income: —
Matched citations: S. 3101
H.R. 1908 and S. 1145, "Patent Reform Act of 2007"; specifically provisions related to apportionment and second window language.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1908
Investment in America Act of 2007
2008 · first_quarter · Firm: C. R. BARD, INC
S. 2209, "Research Credit Improvement Act of 2007"; specifically provisions related to the extension of the Research and Development tax credit. H.R. 2138, "Investment in America Act of 2007"; specifically provisions related to the extension of the Research and Development tax credit.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 2138
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
2008 · first_quarter · Firm: C. R. BARD, INC
Lobbying member staff of House and Senate on Medicare brachytherapy reimbursement payment methodology in Medicare bill to modify CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042, "Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2007," to exclude ultrasound guided vascular access procedures from the bill.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 583
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007
2008 · first_quarter · Firm: C. R. BARD, INC
Lobbying member staff of House and Senate on Medicare brachytherapy reimbursement payment methodology in Medicare bill to modify CMS's OPPS rule. Lobbying member staff of House and Senate on H.R. 583 and S. 1042, "Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2007," to exclude ultrasound guided vascular access procedures from the bill.
Client expense: $20,000 · Firm income: —
Matched citations: S. 1042
H.R. 1908 and S. 1145, "Patent Reform Act of 2007"; specifically provisions related to apportionment and second window language.
Client expense: $20,000 · Firm income: —
Matched citations: S. 1145
Physician Payments Sunshine Act of 2007
2008 · first_quarter · Firm: C. R. BARD, INC
S. 2221, "Transparency in Medical Device Pricing Act of 2007"; specifically provisions related to average sale price disclosure and antitrust rules for the medical device industry. S. 2029, "Physicians Payments Sunshine Act of 2007"; specifically provisions related to pre-emption language, aggregate annual payments to physicians, product education and training, penalties, etc.
Client expense: $20,000 · Firm income: —
Matched citations: S. 2029
Source: Senate LDA